Skip to main
BLCO
BLCO logo

BLCO Stock Forecast & Price Target

BLCO Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 27%
Hold 53%
Sell 7%
Strong Sell 0%

Bulls say

Bausch & Lomb's stock outlook appears positive due to its consistent growth across various segments, highlighted by a 13% year-over-year increase in surgical revenues to $231 million and a notable 67% growth in premium intraocular lenses from the enVista Envy launch. Additionally, the company's consumer segment generated $476 million in revenues, reflecting an 8% year-over-year growth that exceeded consensus estimates. Furthermore, Bausch & Lomb’s contact lens market share increased to 10%, marking a 40 basis points rise year-over-year, which positions the company favorably within the vision care industry.

Bears say

Bausch & Lomb faces a negative outlook driven by expectations of flat to low-single digit revenue growth, resulting in reduced operating margin improvement and earnings per share (EPS) projections being lowered to $0.67 for 2025 and $0.93 for 2026. Several operational and competitive risks are noted, including slower revenue growth from its product lines, potential market share loss in contact lenses, and disruptions related to commercial execution, which could hinder profitability further. Additionally, the company contends with challenges such as heightened competition from lower-cost providers, macroeconomic factors like currency fluctuations, and ongoing geopolitical tensions, which could suppress market valuation for an extended period.

BLCO has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 27% recommend Buy, 53% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bausch + Lomb Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bausch + Lomb Corp (BLCO) Forecast

Analysts have given BLCO a Hold based on their latest research and market trends.

According to 15 analysts, BLCO has a Hold consensus rating as of Jul 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bausch + Lomb Corp (BLCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.